Linkas syrup fl. 90ml
Dosage:
etc.
x 120ml
etc.
x 150ml
etc.
x 90ml
Category
Thinning phlegm
,
Expectorants
Scope of the drug
Respiratory system
Release form
Syrup
Manufacturer country
Pakistan
Package quantity, pcs
one
Release form
Syrup.
Packaging
90 ml.
pharmachologic effect
Linkas is a combined herbal preparation.
Reduces the intensity and increases the productivity of cough, has an expectorant, mucolytic and anti-inflammatory effect.
Adhatoda vascular has an antitussive, bronchodilator, expectorant and antispasmodic effect.
Licorice root contains glycyrrhizin and foaming substances - saponins, which increase the secretory function of the epithelium of the respiratory tract, change the surface-active properties of the pulmonary surfactant, stimulate the movement of epithelial cilia, liquefy phlegm and facilitate its discharge.
It has a depressing effect on the exudative and proliferative phase of inflammation.
It has anti-allergic properties.
Long pepper has antibacterial, anti-allergic properties.
It has an antitussive and tonic effect.
Fragrant violet has anti-inflammatory, analgesic, soothing, antimicrobial and antispasmodic effects.
Common hyssop contains diosmin, which has antiseptic, anti-inflammatory, analgesic and antitussive effects.
Kalgan large has a bactericidal effect, has anti-inflammatory and expectorant properties.
Marshmallow has an expectorant and anti-inflammatory effect.
Ziziphus vulgaris has an expectorant effect, relieves sore throat, has sedative and antibacterial properties.
Indications
Symptomatic therapy of infectious and inflammatory diseases of the respiratory tract, accompanied by a cough with difficult sputum (against the background of ARVI, influenza, tracheitis, bronchitis, tracheobronchitis, pneumonia, smoker's bronchitis and other inflammatory diseases of the respiratory tract)
Contraindications
- children up to 6 months old
- increased individual sensitivity to drug components.
The drug is used with caution in diabetes mellitus.
special instructions
The syrup contains sucrose (70%), which must be taken into account when prescribing the drug to patients with diabetes mellitus and to patients following a hypocaloric diet.
It is not recommended to take Linkas simultaneously with antitussive drugs, as well as drugs that reduce the formation of sputum.
Structure
Dry extract of leaves of adhatoda vascular, dry extract of licorice roots, dry extract of fruits and roots of long pepper, dry extract of fragrant violet flowers, dry extract of leaves of hyssop officinalis, dry extract of roots and rhizomes of alpinia galanga, dry extract of cordia broadleaf fruits, dry extract of marshmallow flowers medicinal, dry extract of Ziziphus real fruit, dry extract of leaves and flowers of onosma bracts.
Excipients: sucrose, citric acid anhydrous, glycerol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, propylene glycol, peppermint oil, clove oil, purified water.
Method of administration and dosage
Children aged 6 months to 3 years are prescribed 1/2 teaspoon (2.5 ml) 3 times / day
children aged 3 to 8 years - 1 teaspoon (5 ml) 3 times / day
children and adolescents aged 8 to 18 years - 1 teaspoon 4 times / day.
For adults, the drug is prescribed 2 teaspoons of syrup 3-4 times / day.
The average duration of the course of treatment is 5-7 days or more, depending on the clinical picture of the disease.
Side effects
Rarely: allergic reactions.
Overdose
To date, no cases of overdose of Linkas have been reported.
Storage conditions
At a temperature not exceeding 25 В° C.
Name ENG
LINKUS
Clinical and pharmacological group
Phytopreparation with expectorant action
ATX code
Combined drugs
Dosage
etc.
x 90ml
Structure
Active ingredients: adhatodes of vascular leaves dry extract (Adhatoda vasica Ness.) 600 mg dry licorice root extract (Glycyrrhiza glabra L.) 75 mg dry pepper and root extract (Piper longum L.) 100 mg fragrant violets dry extract (Viola odorata L.) 25 mg hyssop medicinal leaves dry extract (Hyssopus officinalis L.) 50 mg alpinia galanga roots and rhizomes extract (Alpinia galanga L.) 50 mg Cordia broadleaf fruits dry extract (Cordia latifolia) 100 mg Marshmallow officinalis flowers dry extract (Althaea officinalis L.) 100 mg Ziziphus real fruit dry extract (Ziziphus jujuba Mill.) 100 mg onosms of bractal leaves and flowers dry extract (Onosma bracteatum Wall.) 100 mg Excipients: sucrose citric acid anhydrous glycerol methyl parahydroxybenzoate propyl parahydroxybenzoate propylene glycol peppermint oil clove oil purified water.
Indications
Symptomatic therapy of infectious and inflammatory diseases of the respiratory tract, accompanied by cough with difficult sputum (against the background of acute respiratory diseases, influenza, tracheitis, bronchitis, tracheobronchitis, pneumonia, bronchitis of smokers" and other inflammatory diseases of the respiratory tract).
Contraindications
Hypersensitivity to the drug components, children up to 6 months of age, pregnancy and breastfeeding, sucrase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption.
With care: Diabetes mellitus.
INN / Active ingredient
Violets of fragrant flowers dry extract + hyssop medicinal leaves dry extract + alpinia galanga roots and rhizomes dry extract + licorice root dry extract + marshmallow flower extract dry + pepper long fruit and roots dry extract + ziziphus real fruit dry extract + cordia broadleaf fruit extract dry + onosms of bractal leaves and flowers dry extract + vascular leaf adatodes dry extract
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
Specifications
Category
Thinning phlegm
,
Expectorants
Scope of the drug
Respiratory system
Release form
Syrup
Manufacturer country
Pakistan
Package quantity, pcs
one
Scope of application
Virology
Minimum age from
From birth
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Herbion
Components
measuring cap
The amount of the dosage form in the primary package
90 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Herbal expectorant
Dosage form
Syrup
The target audience
Children
Expiration date in days
1095
Package weight, g
2
Mode of application
:
Inside, children from 6 months to 3 years old - 1/2 teaspoon (2.5 ml) 3 times a day
3�8 years old - 1 teaspoon (5 ml) 3 times a day
8-18 years old - 1 teaspoon 4 times a day
adults - 2 teaspoons 3-4 times a day. < br> Duration of use of the drug - 5-7 days.
An increase in the duration and repeated courses of treatment is possible on the recommendation of a doctor.
Information on technical characteristics, delivery set, country of manufacture "